ID   MARK2_RAT               Reviewed;         722 AA.
AC   O08679;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   29-MAY-2024, entry version 177.
DE   RecName: Full=Serine/threonine-protein kinase MARK2;
DE            EC=2.7.11.1;
DE            EC=2.7.11.26;
DE   AltName: Full=ELKL motif kinase 1;
DE            Short=EMK-1;
DE   AltName: Full=MAP/microtubule affinity-regulating kinase 2;
GN   Name=Mark2 {ECO:0000312|RGD:708483};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAB06295.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:CAB06295.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:CAB06295.1};
RX   PubMed=9108484; DOI=10.1016/s0092-8674(00)80208-1;
RA   Drewes G., Ebneth A., Preuss U., Mandelkow E.-M., Mandelkow E.;
RT   "MARK - a novel family of protein kinases that phosphorylate microtubule-
RT   associated proteins and trigger microtubule disruption.";
RL   Cell 89:297-308(1997).
RN   [2]
RP   FUNCTION, ACTIVITY REGULATION, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT
RP   THR-58; THR-208; SER-212; SER-274 AND THR-275, AND MUTAGENESIS OF THR-208
RP   AND SER-212.
RX   PubMed=14517247; DOI=10.1093/emboj/cdg447;
RA   Timm T., Li X.Y., Biernat J., Jiao J., Mandelkow E., Vandekerckhove J.,
RA   Mandelkow E.M.;
RT   "MARKK, a Ste20-like kinase, activates the polarity-inducing kinase
RT   MARK/PAR-1.";
RL   EMBO J. 22:5090-5101(2003).
RN   [3]
RP   FUNCTION.
RX   PubMed=15466480; DOI=10.1083/jcb.200401085;
RA   Mandelkow E.M., Thies E., Trinczek B., Biernat J., Mandelkow E.;
RT   "MARK/PAR1 kinase is a regulator of microtubule-dependent transport in
RT   axons.";
RL   J. Cell Biol. 167:99-110(2004).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF DCX, AND SUBCELLULAR LOCATION.
RX   PubMed=14741102; DOI=10.1016/s0896-6273(03)00843-2;
RA   Schaar B.T., Kinoshita K., McConnell S.K.;
RT   "Doublecortin microtubule affinity is regulated by a balance of kinase and
RT   phosphatase activity at the leading edge of migrating neurons.";
RL   Neuron 41:203-213(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-212, AND MUTAGENESIS OF THR-208 AND SER-212.
RX   PubMed=16257959; DOI=10.1074/jbc.m507941200;
RA   Kosuga S., Tashiro E., Kajioka T., Ueki M., Shimizu Y., Imoto M.;
RT   "GSK-3beta directly phosphorylates and activates MARK2/PAR-1.";
RL   J. Biol. Chem. 280:42715-42722(2005).
RN   [6]
RP   INTERACTION WITH PAK5.
RX   PubMed=16014608; DOI=10.1091/mbc.e05-01-0081;
RA   Matenia D., Griesshaber B., Li X.Y., Thiessen A., Johne C., Jiao J.,
RA   Mandelkow E., Mandelkow E.M.;
RT   "PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable
RT   microtubules and dynamic actin.";
RL   Mol. Biol. Cell 16:4410-4422(2005).
RN   [7]
RP   PHOSPHORYLATION AT THR-539, MUTAGENESIS OF THR-539, AND FUNCTION.
RX   PubMed=16717194; DOI=10.1073/pnas.0509955103;
RA   Chen Y.M., Wang Q.J., Hu H.S., Yu P.C., Zhu J., Drewes G.,
RA   Piwnica-Worms H., Luo Z.G.;
RT   "Microtubule affinity-regulating kinase 2 functions downstream of the PAR-
RT   3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:8534-8539(2006).
RN   [8]
RP   PHOSPHORYLATION AT SER-91; SER-92; SER-93 AND THR-294, AND MUTAGENESIS OF
RP   LYS-82; 91-SER--SER-93 AND THR-294.
RX   PubMed=17442826; DOI=10.1523/jneurosci.0725-07.2007;
RA   Uboha N.V., Flajolet M., Nairn A.C., Picciotto M.R.;
RT   "A calcium- and calmodulin-dependent kinase Ialpha/microtubule affinity
RT   regulating kinase 2 signaling cascade mediates calcium-dependent neurite
RT   outgrowth.";
RL   J. Neurosci. 27:4413-4423(2007).
RN   [9]
RP   PHOSPHORYLATION AT SER-212, AND MUTAGENESIS OF THR-208 AND SER-212.
RX   PubMed=18424437; DOI=10.1074/jbc.m706596200;
RA   Timm T., Balusamy K., Li X., Biernat J., Mandelkow E., Mandelkow E.M.;
RT   "Glycogen synthase kinase (GSK) 3beta directly phosphorylates Serine 212 in
RT   the regulatory loop and inhibits microtubule affinity-regulating kinase
RT   (MARK) 2.";
RL   J. Biol. Chem. 283:18873-18882(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=18509032; DOI=10.1523/jneurosci.0911-08.2008;
RA   Sapir T., Sapoznik S., Levy T., Finkelshtein D., Shmueli A., Timm T.,
RA   Mandelkow E.M., Reiner O.;
RT   "Accurate balance of the polarity kinase MARK2/Par-1 is required for proper
RT   cortical neuronal migration.";
RL   J. Neurosci. 28:5710-5720(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408; SER-409; SER-453 AND
RP   SER-483, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 39-364 OF WILD-TYPE AND MUTANT
RP   THR-208 AND SER-212, AND SUBUNIT.
RX   PubMed=16472737; DOI=10.1016/j.str.2005.09.022;
RA   Panneerselvam S., Marx A., Mandelkow E.M., Mandelkow E.;
RT   "Structure of the catalytic and ubiquitin-associated domains of the protein
RT   kinase MARK/Par-1.";
RL   Structure 14:173-183(2006).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) OF 39-364.
RX   PubMed=20071654; DOI=10.1096/fj.09-148064;
RA   Marx A., Nugoor C., Panneerselvam S., Mandelkow E.;
RT   "Structure and function of polarity-inducing kinase family MARK/Par-1
RT   within the branch of AMPK/Snf1-related kinases.";
RL   FASEB J. 24:1637-1648(2010).
CC   -!- FUNCTION: Serine/threonine-protein kinase. Involved in cell polarity
CC       and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX,
CC       HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the
CC       microtubule-associated protein MAPT/TAU. Plays a key role in cell
CC       polarity by phosphorylating the microtubule-associated proteins MAP2,
CC       MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules,
CC       and their disassembly. Regulates epithelial cell polarity by
CC       phosphorylating RAB11FIP2. Involved in the regulation of neuronal
CC       migration through its dual activities in regulating cellular polarity
CC       and microtubule dynamics, possibly by phosphorylating and regulating
CC       DCX. Regulates axogenesis by phosphorylating KIF13B, promoting
CC       interaction between KIF13B and 14-3-3 and inhibiting microtubule-
CC       dependent accumulation of KIF13B. Also required for neurite outgrowth
CC       and establishment of neuronal polarity. Regulates localization and
CC       activity of some histone deacetylases by mediating phosphorylation of
CC       HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and
CC       export from the nucleus. Also acts as a positive regulator of the Wnt
CC       signaling pathway, probably by mediating phosphorylation of dishevelled
CC       proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision
CC       to build a columnar versus a hepatic epithelial cell apparently by
CC       promoting a switch from a direct to a transcytotic mode of apical
CC       protein delivery. Essential for the asymmetric development of membrane
CC       domains of polarized epithelial cells. {ECO:0000250|UniProtKB:Q7KZI7,
CC       ECO:0000269|PubMed:14517247, ECO:0000269|PubMed:14741102,
CC       ECO:0000269|PubMed:15466480, ECO:0000269|PubMed:16717194,
CC       ECO:0000269|PubMed:18509032}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q7KZI7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q7KZI7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-
CC         COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703,
CC         Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.26;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q7KZI7};
CC   -!- ACTIVITY REGULATION: Inhibited by hymenialdisine (By similarity).
CC       Activated by phosphorylation on Thr-208 by STK11/LKB1 and TAOK1.
CC       Inhibited by phosphorylation at Ser-212 or Thr-539. Inhibited by PAK5;
CC       inhibition is independent of the kinase activity of PAK5. {ECO:0000250,
CC       ECO:0000269|PubMed:14517247}.
CC   -!- SUBUNIT: Homodimer (PubMed:16472737). Interacts (when phosphorylated at
CC       Thr-539) with YWHAZ (By similarity). Interacts with MTCL1; the
CC       interaction is direct and increases MARK2 microtubule-binding ability
CC       (By similarity). Interacts with PAK5; leading to inhibit the protein
CC       kinase activity (PubMed:16014608). Interacts with MAPT/TAU (By
CC       similarity). Interacts with YWHAB, YWHAG and YWHAQ (By similarity).
CC       {ECO:0000250|UniProtKB:Q7KZI7, ECO:0000269|PubMed:16014608,
CC       ECO:0000269|PubMed:16472737}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14741102};
CC       Peripheral membrane protein {ECO:0000269|PubMed:14741102}. Lateral cell
CC       membrane {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q7KZI7}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q7KZI7}. Note=Phosphorylation at Thr-539 by
CC       PRKCZ/aPKC and subsequent interaction with 14-3-3 protein YWHAZ
CC       promotes relocation from the cell membrane to the cytoplasm.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The KA1 domain mediates binding to phospholipids and targeting
CC       to membranes. {ECO:0000250}.
CC   -!- DOMAIN: The UBA domain does not seem to bind ubiquitin and ubiquitin-
CC       like and might play a role in regulating the enzyme conformation and
CC       localization. Activation of the kinase activity following
CC       phosphorylation at Thr-208 is accompanied by a conformational change
CC       that alters the orientation of the UBA domain with respect to the
CC       catalytic domain (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. Phosphorylated at Thr-208 by STK11/LKB1 in
CC       complex with STE20-related adapter-alpha (STRADA) pseudo kinase and
CC       CAB39. Phosphorylation at Thr-208 by TAOK1 activates the kinase
CC       activity, leading to phosphorylation and detachment of MAPT/TAU from
CC       microtubules. Phosphorylation at Ser-212 by GSK3-beta (GSK3B) inhibits
CC       the kinase activity. Phosphorylation by CaMK1 promotes activity and is
CC       required to promote neurite outgrowth. Phosphorylation at Thr-539 by
CC       PRKCZ/aPKC in polarized epithelial cells inhibits the kinase activity
CC       and promotes binding to 14-3-3 protein YWHAZ, leading to relocation
CC       from cell membrane to cytoplasm. {ECO:0000269|PubMed:14517247,
CC       ECO:0000269|PubMed:16257959, ECO:0000269|PubMed:16717194,
CC       ECO:0000269|PubMed:17442826, ECO:0000269|PubMed:18424437}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z83869; CAB06295.1; -; mRNA.
DR   RefSeq; NP_067731.1; NM_021699.1.
DR   PDB; 1Y8G; X-ray; 2.50 A; A/B=39-364.
DR   PDB; 1ZMU; X-ray; 2.90 A; A/B=39-364.
DR   PDB; 1ZMV; X-ray; 3.10 A; A/B=39-364.
DR   PDB; 1ZMW; X-ray; 2.80 A; A/B=39-364.
DR   PDB; 2R0I; X-ray; 2.20 A; A/B=39-364.
DR   PDB; 2WZJ; X-ray; 2.79 A; A/B/C/D/E/F=39-364.
DR   PDBsum; 1Y8G; -.
DR   PDBsum; 1ZMU; -.
DR   PDBsum; 1ZMV; -.
DR   PDBsum; 1ZMW; -.
DR   PDBsum; 2R0I; -.
DR   PDBsum; 2WZJ; -.
DR   AlphaFoldDB; O08679; -.
DR   SMR; O08679; -.
DR   BioGRID; 248778; 1.
DR   DIP; DIP-29029N; -.
DR   IntAct; O08679; 1.
DR   MINT; O08679; -.
DR   STRING; 10116.ENSRNOP00000073980; -.
DR   iPTMnet; O08679; -.
DR   PhosphoSitePlus; O08679; -.
DR   PaxDb; 10116-ENSRNOP00000028763; -.
DR   GeneID; 60328; -.
DR   KEGG; rno:60328; -.
DR   UCSC; RGD:708483; rat.
DR   AGR; RGD:708483; -.
DR   CTD; 2011; -.
DR   RGD; 708483; Mark2.
DR   VEuPathDB; HostDB:ENSRNOG00000021184; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   InParanoid; O08679; -.
DR   OrthoDB; 5475340at2759; -.
DR   EvolutionaryTrace; O08679; -.
DR   PRO; PR:O08679; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000021184; Expressed in jejunum and 19 other cell types or tissues.
DR   ExpressionAtlas; O08679; baseline and differential.
DR   GO; GO:0005884; C:actin filament; ISS:UniProtKB.
DR   GO; GO:0045180; C:basal cortex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016328; C:lateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0097427; C:microtubule bundle; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0140677; F:molecular function activator activity; EXP:DisProt.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; IPI:ARUK-UCL.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0061564; P:axon development; IMP:ARUK-UCL.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0071963; P:establishment or maintenance of cell polarity regulating cell shape; IMP:ARUK-UCL.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0001764; P:neuron migration; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ARUK-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:1904526; P:regulation of microtubule binding; IMP:ARUK-UCL.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IDA:ARUK-UCL.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd12201; MARK2_C; 1.
DR   CDD; cd14072; STKc_MARK; 1.
DR   CDD; cd14406; UBA_MARK2; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1.
DR   Gene3D; 3.30.310.80; Kinase associated domain 1, KA1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR028375; KA1/Ssp2_C.
DR   InterPro; IPR001772; KA1_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR049508; MARK1-4_cat.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   PANTHER; PTHR24346; MAP/MICROTUBULE AFFINITY-REGULATING KINASE; 1.
DR   PANTHER; PTHR24346:SF56; SERINE_THREONINE-PROTEIN KINASE MARK2; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00627; UBA; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF103243; KA1-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Differentiation; Kinase;
KW   Lipid-binding; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Wnt signaling pathway.
FT   CHAIN           1..722
FT                   /note="Serine/threonine-protein kinase MARK2"
FT                   /id="PRO_0000086303"
FT   DOMAIN          53..304
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          323..362
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   DOMAIN          673..722
FT                   /note="KA1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00565"
FT   REGION          1..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          373..576
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        378..429
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        430..444
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..576
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        175
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H0K1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         59..67
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H0K1,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         82
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O08678,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         58
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:14517247"
FT   MOD_RES         91
FT                   /note="Phosphoserine; by CaMK1"
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MOD_RES         92
FT                   /note="Phosphoserine; by CaMK1"
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MOD_RES         93
FT                   /note="Phosphoserine; by CaMK1"
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MOD_RES         208
FT                   /note="Phosphothreonine; by LKB1 and TAOK1"
FT                   /evidence="ECO:0000269|PubMed:14517247"
FT   MOD_RES         212
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:16257959, ECO:0000269|PubMed:18424437"
FT   MOD_RES         274
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:14517247"
FT   MOD_RES         275
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:14517247"
FT   MOD_RES         294
FT                   /note="Phosphothreonine; by CaMK1"
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MOD_RES         408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         409
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         464
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         512
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         514
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         539
FT                   /note="Phosphothreonine; by PKC/PRKCZ"
FT                   /evidence="ECO:0000269|PubMed:16717194"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MOD_RES         656
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7KZI7"
FT   MUTAGEN         82
FT                   /note="K->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MUTAGEN         91..93
FT                   /note="SSS->AAA: Loss of phosphorylation by CaMK1, decrease
FT                   in kinase activity and ability to promote neurite
FT                   outgrowth; when associated with A-294."
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MUTAGEN         208
FT                   /note="T->A: Abolishes activation of serine/threonine-
FT                   protein kinase activity and only basal activity remains."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:16257959, ECO:0000269|PubMed:18424437"
FT   MUTAGEN         208
FT                   /note="T->E: Phosphomimetic mutant that leads to activation
FT                   but not in presence of GSK3-beta."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:16257959, ECO:0000269|PubMed:18424437"
FT   MUTAGEN         212
FT                   /note="S->A: Loss of activity; neither activated by TAOK1
FT                   nor by STK11/LKB1."
FT                   /evidence="ECO:0000269|PubMed:14517247,
FT                   ECO:0000269|PubMed:16257959, ECO:0000269|PubMed:18424437"
FT   MUTAGEN         294
FT                   /note="T->A: Loss of phosphorylation by CaMK1, decrease in
FT                   kinase activity and ability to promote neurite outgrowth;
FT                   when associated with 91-A--A-93."
FT                   /evidence="ECO:0000269|PubMed:17442826"
FT   MUTAGEN         539
FT                   /note="T->A: Abolishes phosphorylation by PKC/PRKCZ."
FT                   /evidence="ECO:0000269|PubMed:16717194"
FT   STRAND          53..61
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          63..72
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          78..85
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           91..106
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          115..120
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          122..130
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           137..144
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           149..168
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   STRAND          194..196
FT                   /evidence="ECO:0007829|PDB:2WZJ"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:2WZJ"
FT   TURN            208..211
FT                   /evidence="ECO:0007829|PDB:1Y8G"
FT   HELIX           213..215
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           219..222
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           229..245
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           255..264
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           275..284
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           295..298
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           302..305
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           326..334
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           339..347
FT                   /evidence="ECO:0007829|PDB:2R0I"
FT   HELIX           353..361
FT                   /evidence="ECO:0007829|PDB:2R0I"
SQ   SEQUENCE   722 AA;  80872 MW;  2CBAFD1C38007ECC CRC64;
     MSSARTPLPT LNERDTEQPT LGHLDSKPSS KSNMLRGRNS ATSADEQPHI GNYRLLKTIG
     KGNFAKVKLA RHILTGKEVA VKIIDKTQLN SSSLQKLFRE VRIMKVLNHP NIVKLFEVIE
     TEKTLYLVME YASGGEVFDY LVAHGRMKEK EARAKFRQIV SAVQYCHQKF IVHRDLKAEN
     LLLDADMNIK IADFGFSNEF TFGNKLDTFC GSPPYAAPEL FQGKKYDGPE VDVWSLGVIL
     YTLVSGSLPF DGQNLKELRE RVLRGKYRIP FYMSTDCENL LKKFLILNPS KRGTLEQIMK
     DRWMNVGHED DELKPYVEPL PDYKDPRRTE LMVSMGYTRE EIQDSLVGQR YNEVMATYLL
     LGYKSSELEG DTITLKPRPS ADLTNSSAPS PSHKVQRSVS ANPKQRRSSD QAVPAIPTSN
     SYSKKTQSNN AENKRPEEET GRKASSTAKV PASPLPGLDR KKTTPTPSTN SVLSTSTNRS
     RNSPLLDRAS LGQASIQNGK DSTAPQRVPV ASPSAHNISS SSGAPDRTNF PRGVSSRSTF
     HAGQLRQVRD QQNLPFGVTP ASPSGHSQGR RGASGSIFSK FTSKFVRRNL NEPESKDRVE
     TLRPHVVGGG GTDKEKEEFR EAKPRSLRFT WSMKTTSSME PNEMMREIRK VLDANSCQSE
     LHERYMLLCV HGTPGHENFV QWEMEVCKLP RLSLNGVRFK RISGTSMAFK NIASKIANEL
     KL
//
